James Bayrer

Dr. James Bayrer

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Nature
Verified
Journal Article
Closed access
PDF file
JBJames Bayrer
James Bayrer
JCJoel Castro
Joel Castro
AVArchana Venkataraman
Archana Venkataraman
KTKouki K. Touhara
Kouki K. Touhara
NRNathan D. Rossen
Nathan D. Rossen
DJDavid Julius
David Julius

1 February 2017 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
TWThomas E. Wallach
Thomas E. Wallach
JBJames Bayrer
James Bayrer

30 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KMKevin Man
Kevin Man
CBChristopher Bowman
Christopher Bowman
KBKristina N. Braverman
Kristina N. Braverman
VEVeronica Escalante
Veronica Escalante
YTYuan Tian
Yuan Tian
ACAjay Chawla
Ajay Chawla
Significance: Disease tolerance is a host defense strategy that protects tissues from damage caused by pathogens or the immune system. While the importance of disease tolerance is well established in pathogenic infections, its role in tissue protection in noninfectious diseases remains less well understood. Here, we provide a framework for investigating the mechanisms of disease tolerance in experimental models of colitis. We find that the program of disease tolerance is preferentially expressed in thermoneutral mice, which protects them from injury-induced colitis and inflammation-induced colon cancer. The expression of intestinal disease tolerance is mediated by an unexpected cross-talk between thermogenic adipocytes and intestinal epithelial cells, suggesting that disease tolerance programs are metabolically expensive and dependent on the energetic state of the host.

4 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJames Bayrer
James Bayrer
HWHongtao Wang
Hongtao Wang
RNRoy Nattiv
Roy Nattiv
MSMiyuki Suzawa
Miyuki Suzawa
HEHazel S. Escusa
Hazel S. Escusa
HIHolly A. Ingraham
Holly A. Ingraham
Epithelial dysfunction and loss of intestinal crypts are defining features of inflammatory bowel disease (IBD). However, current therapies primarily target the immune system and not the epithelium. The nuclear receptor LRH-1 encoded by Nr5a2 is expressed in intestinal epithelium and is thought to contribute to epithelial renewal. Here we investigate how loss and gain of LRH-1 impacts the intestinal epithelium in healthy and inflammatory conditions. Knocking out LRH-1 in murine intestinal organoids reduces Notch signaling, increases crypt cell death and weakens the epithelial barrier. Loss of LRH-1 also distorts the cellular composition of the epithelium, resulting in an expansion of Paneth and goblet cells, and a decrease in enteroendocrine cells. Human LRH-1 (hLRH-1) not only rescues epithelial integrity, but when overexpressed, mitigates inflammatory damage in mouse and human intestinal organoids, including those from IBD patients. Finally, hLRH-1 greatly reduces disease severity in a mouse model of T cell-mediated colitis. Together with the failure of a ligand-incompetent hLRH-1 mutant to protect against TNFα-damage, these findings provide compelling evidence that hLRH-1 mediates epithelial homeostasis and is an attractive target for intestinal disease.

5 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
CHCandice B. Herber
Candice B. Herber
WKWilliam C. Krause
William C. Krause
LWLiping Wang
Liping Wang
JBJames Bayrer
James Bayrer
ALAlfred Li
Alfred Li
HIHolly A. Ingraham
Holly A. Ingraham
Central estrogen signaling coordinates energy expenditure, reproduction, and in concert with peripheral estrogen impacts skeletal homeostasis in female rodents. Here, we ablate estrogen receptor alpha (ERα) in the medial basal hypothalamus and find a robust bone phenotype only in female mice that results in exceptionally strong trabecular and cortical bones, whose density surpasses other reported mouse models. Stereotaxic guided deletion of ERα in the arcuate nucleus increases bone mass in both intact and estrogen-depleted females, confirming the central role of estrogen signaling in this sex-dependent bone phenotype. Loss of ERα activity in kisspeptin ( Kiss1 )-expressing cells is sufficient to recapitulate the bone phenotype, identifying Kiss1 neurons as a critical node in this powerful neuroskeletal circuit. We propose that this newly identified female brain-to-bone pathway exists as a homeostatic regulator to divert calcium and energy stores from bone building when energetic demands are high. Our work reveals a previously unknown target for the treatment of age-related bone disease.

19 September 2022
Verified
Preprint
Open access
PDF file
JBJames Bayrer
James Bayrer
Protocol for measuring the visceromotor response (VMR) to colorectal distension in mice to investigate visceral nociception.